0001209191-23-010050.txt : 20230216 0001209191-23-010050.hdr.sgml : 20230216 20230216161412 ACCESSION NUMBER: 0001209191-23-010050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230214 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arbuckle Stuart A CENTRAL INDEX KEY: 0001557290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 23638669 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-14 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001557290 Arbuckle Stuart A C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, COO Common Stock 2023-02-14 4 S 0 800 295.84 D 81203 D Common Stock 2023-02-14 4 S 0 901 296.85 D 80302 D Common Stock 2023-02-14 4 S 0 560 298.14 D 79742 D Common Stock 2023-02-14 4 S 0 2003 299.13 D 77739 D Common Stock 2023-02-14 4 S 0 1734 300.09 D 76005 D Common Stock 2023-02-14 4 S 0 400 300.89 D 75605 D Common Stock 140 I 401(k) Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1. Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $295.84 (range $295.34 to $296.20). Open market sales reported on this line occurred at a weighted average price of $296.85 (range $296.49 to $297.30). Open market sales reported on this line occurred at a weighted average price of $298.14 (range $297.59 to $298.57). Open market sales reported on this line occurred at a weighted average price of $299.13 (range $298.68 to $299.60). Open market sales reported on this line occurred at a weighted average price of $300.09 (range $299.73 to $300.70). Open market sales reported on this line occurred at a weighted average price of $300.89 (range $300.78 to $301.03). /s/ Christiana Stevenson, Attorney-in-Fact 2023-02-16